Paul Tudor Jones Siga Technologies Inc Transaction History

Tudor Investment Corp Et Al

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$6.5 - $13.68 $207,155 - $435,981	31,870 New	31,870 $369,000
Q3 2021 Nov 15, 2021	SELL	$5.71 - $7.39 $216,763 - $280,539	-37,962 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.1 - $7.58 $248,495 - $308,786	-40,737 Reduced 51.76%	37,962 $238,000
Q1 2021 May 17, 2021	BUY	$6.3 - $7.71 $125,433 - $153,506	19,910 Added 33.87%	78,699 $512,000
Q4 2020 Feb 16, 2021	SELL	$6.39 - $7.76 $99,984 - $121,420	-15,647 Reduced 21.02%	58,789 $427,000
Q3 2020 Nov 16, 2020	BUY	$5.62 - $7.68 $205,292 - $280,542	36,529 Added 96.36%	74,436 $511,000
Q2 2020 Aug 14, 2020	BUY	$4.55 - $6.19 $172,476 - $234,644	37,907 New	37,907 $224,000

185

35.6M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $432M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.